)
)
Carmat Investor Relations Material
Latest events
Trading Update
Carmat
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Carmat SA
Access all reports
Carmat SA is a French medical technology company that specializes in the development and manufacturing of advanced artificial heart systems. The company's flagship product is the Aeson, a biocompatible, fully implantable total artificial heart designed to provide a life-saving alternative for patients suffering from end-stage biventricular heart failure. Carmat's innovative heart prosthesis mimics the natural human heart's functions and aims to bridge the gap for patients awaiting heart transplants. Carmat SA is headquartered in Vélizy-Villacoublay, France, and its shares are listed on the Euronext Paris.
Key slides for Carmat SA
Trading Update
Carmat SA
H2 2023
Carmat SA
Latest articles
)
House of Pinault: The History and Business of Kering and Gucci
Kering is a luxury group under the Pinault family's leadership, managing iconic brands like Gucci, Saint Laurent, and Bottega Veneta.
19 Dec 2024
)
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
)
Lessons from Gautam Baid: Mastering Simplicity and Compounding
Gautam Baid's journey of compounding wisdom, investing simplicity, and lifelong learning – insights to transform your financial and personal growth.
13 Dec 2024
Ticker symbol
ALCAR
Country
🇫🇷 France